Movement Alert｜Twist Bioscience Corp Falls 5.08% in Regular Trading, Position Change Disclosure Keeps Volatility in Focus

Market Focus10-22

On October 22, Twist Bioscience Corp fell 5.08% in Regular Trading, trading at $141.425 per share, with turnover of $71.2574 million.

The move followed continued market focus on a previously disclosed position change involving Laponis Adam, an event that has remained an active public catalyst for the stock.

Recent trading around the same disclosure has been highly volatile: the stock was reported down 5.1% overnight, down 5.85% in pre-market activity, and had also risen 5.16% in an earlier session. Analyst views remain mixed, with Jefferies assigning a Hold rating and $150 target price, while UBS maintained a Neutral rating and $144 target price, underscoring ongoing disagreement over near-term valuation.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment